| MDL | MFCD00063089 |
|---|---|
| Molecular Weight | 196.11 |
| Molecular Formula | C5H11NO2Se |
| SMILES | O=C(O)C(N)CC[Se]C |
Selenomethionine is a naturally occurring amino acid containing selenium, is a common natural food source of selenium.
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT00736645 | Roswell Park Cancer Institute |
Prostate Cancer
|
August 2008 | Phase 2 |
| NCT05363631 | Yousef Zakharia|University of Iowa |
Clear Cell Renal Cell Carcinoma|Clear Cell Renal Cell Carcinoma Metastatic
|
September 19, 2022 | Phase 1|Phase 2 |
| NCT00736164 | Roswell Park Cancer Institute|National Cancer Institute (NCI) |
Prostate Cancer
|
August 2008 | Phase 2 |
| NCT00625183 | Roswell Park Cancer Institute|National Cancer Institute (NCI) |
Colorectal Cancer
|
March 2008 | Phase 2 |
| NCT04952129 | University of Auckland, New Zealand|Cancer Trials New Zealand|Counties Manukau Health|Waikato Hospital |
Colorectal Adenoma
|
August 1, 2021 | Phase 1 |
| NCT02535533 | Yousef Zakharia|Pfizer|University of Iowa |
Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)
|
January 2016 | Phase 1|Phase 2 |
| NCT01682031 | Roswell Park Cancer Institute|National Cancer Institute (NCI) |
Chemotherapeutic Agent Toxicity|Mucositis|Radiation Toxicity|Stage III Squamous Cell Carcinoma of the Hypopharynx|Stage III Squamous Cell Carcinoma of the Larynx|Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage III Squamous Cell Carcinoma of the Nasopharynx|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squamous Cell Carcinoma of the Larynx|Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IV Squamous Cell Carcinoma of the Nasopharynx|Stage IV Squamous Cell Carcinoma of the Oropharynx|Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Xerostomia
|
June 2009 | Phase 2 |
| NCT00526890 | Roswell Park Cancer Institute |
Lung Cancer
|
October 2006 | Phase 2 |
| NCT01211561 | University of Illinois at Chicago |
Prevention of Colorectal Cancer
|
December 2010 | Early Phase 1 |
| NCT01112449 | Milton S. Hershey Medical Center |
Effect of Selenium on Oxidative Stress in Healthy Men
|
May 2008 | Not Applicable |
| NCT02302768 | University of Siena|IBSA Institut Biochimique SA |
Thyroiditis Autoimmune
|
December 2012 | Phase 2 |
| NCT00271245 | Vanderbilt University|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
Liver Disease
|
February 2006 | Not Applicable |
Solid
Room temperature in continental US; may vary elsewhere.
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
H 2 O : 12.5 mg/mL ( 63.74 mM ; Need ultrasonic)
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 5.0992 mL | 25.4959 mL | 50.9918 mL |
| 5 mM | 1.0198 mL | 5.0992 mL | 10.1984 mL |
| 10 mM | 0.5099 mL | 2.5496 mL | 5.0992 mL |
Add each solvent one by one: PBS
Solubility: 10 mg/mL (50.99 mM); Clear solution; Need ultrasonic and warming and heat to 60°C